Latest Rome process Stories
MEBANE, N.C., June 1 /PRNewswire/ -- Behavioral Health Associates of NC, Inc. announces the release for sale of the iPhone symptom tracker application for Irritable Bowel Syndrome.
-- Data Presented Today at DDW Demonstrate Linaclotide Provided Early Onset of Abdominal Pain Relief and Improved Bowel Habits -- CAMBRIDGE, Mass. and NEW YORK, May 31, 2009 /PRNewswire-FirstCall/ -- Ironwood Pharmaceuticals, Inc. and Forest Laboratories, Inc.
IBS Signs and Symptoms Tracker Sheds Light on IBS Warning Signs; IBS Treatment Matrix Helps Patients Find Relief BETHESDA, Md., May 29 /PRNewswire-USNewswire/ -- To mark World Digestive Health Day, the American College of Gastroenterology (ACG), in conjunction with global observances of this awareness day under the auspices of the World Gastroenterology Organisation (WGO), today announced the availability of two new interactive tools aimed at helping to provide answers and hope to millions...
Study Adds to Growing Evidence of B.
SAN DIEGO, March 16 /PRNewswire/ -- Prometheus Laboratories Inc., a specialty pharmaceutical and diagnostic company, announced today that it has received New York State approval for PROMETHEUS(R) IBS Diagnostic, the first and only blood test for irritable bowel syndrome (IBS).
Chronic gastrointestinal symptoms are highly prevalent in different geographic populations and cause various gastrointestinal symptoms that greatly inconvenience the lives of those affected.
U-M experts helped develop new evidence-based recommendations put out today by the American College of Gastroenterology U-M Health Minute: Today's top health issues and medical research ANN ARBOR, Mich., Dec.
SAN DIEGO, Oct. 7 /PRNewswire/ -- Prometheus Laboratories Inc., a specialty pharmaceutical company, today announced findings from its development of PROMETHEUS(R) IBS Diagnostic, the first and only blood test for irritable bowel syndrome (IBS).
ORLANDO, Fla., Oct. 6 /PRNewswire/ -- Ironwood Pharmaceuticals (formerly Microbia) today announced presentation of data from a pair of preclinical studies delineating the role that cyclic guanosine monophosphate (cGMP) plays in alleviating intestinal pain.
CAMBRIDGE, Mass., Oct. 1 /PRNewswire/ -- Ironwood Pharmaceuticals, Inc. today announced it has raised $50 million in a private equity financing.
- Growing in low tufty patches.